12/2/2021: 

Developing state-of-the-art vaccines is not a single-company job. In the development process of the Avishield vaccines, Royal GD supported Dechra Pharmaceuticals throughout all the stages. This collaboration will enhance poultry health in several countries, and expansion is on the cards. Matthias Riedel explains on behalf of Dechra why GD has become an essential partner in developing one of their latest products. 

Dechra reached out to GD for the Avishield launch, says Fanny Nieuwenhuis (Senior Account Manager Contract Research at GD). It’s not the first time that the two parties have worked together. This time, the collaboration was intended to support Dechra customers with diagnostic tests to screen their poultry flocks. By using a tailor-made form, customers can easily submit samples from European member states. And it goes further than that, Matthias explains. “The Contract Research team of GD can help us set up and execute the research projects needed to register a vacccine in the European Union, while also supporting our R&D and marketing team. They have the scientific know-how to help us make informed decisions.”

Read more